Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea
· Delayed Price · Currency is KRW 31,600
+750 (2.43%)
Mar 10, 2026, 10:50 AM KST
Ildong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 972,024 | 328,764 | 502,483 | 764,721 | 799,187 | 449,542 | Upgrade
|
| Market Cap Growth | 204.46% | -34.57% | -34.29% | -4.31% | 77.78% | 18.46% | Upgrade
|
| Enterprise Value | 1,069,688 | 467,886 | 480,579 | 872,139 | 869,595 | 531,687 | Upgrade
|
| Last Close Price | 30850.00 | 11770.00 | 18160.00 | 28550.00 | 33600.00 | 18900.00 | Upgrade
|
| PE Ratio | 31.45 | - | - | - | - | - | Upgrade
|
| Forward PE | 22.61 | 14.76 | 14.76 | 14.76 | 14.76 | 14.76 | Upgrade
|
| PS Ratio | 1.69 | 0.54 | 0.84 | 1.20 | 1.43 | 0.80 | Upgrade
|
| PB Ratio | 4.15 | 1.98 | 2.80 | 3.75 | 4.79 | 1.77 | Upgrade
|
| P/TBV Ratio | 4.66 | 2.48 | 3.75 | 4.96 | 7.37 | 2.08 | Upgrade
|
| P/FCF Ratio | 145.61 | 18.67 | - | - | - | 89.66 | Upgrade
|
| P/OCF Ratio | 46.44 | 11.62 | - | - | - | 23.21 | Upgrade
|
| PEG Ratio | - | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | Upgrade
|
| EV/Sales Ratio | 1.86 | 0.76 | 0.80 | 1.37 | 1.55 | 0.95 | Upgrade
|
| EV/EBITDA Ratio | 24.92 | 12.52 | - | - | - | 16.02 | Upgrade
|
| EV/EBIT Ratio | 56.61 | 40.93 | - | - | - | 96.16 | Upgrade
|
| EV/FCF Ratio | 160.24 | 26.56 | - | - | - | 106.04 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 1.24 | 1.19 | 1.02 | 1.36 | 0.66 | Upgrade
|
| Debt / EBITDA Ratio | 3.63 | 5.50 | - | - | - | 5.03 | Upgrade
|
| Debt / FCF Ratio | 23.28 | 11.67 | - | - | - | 33.28 | Upgrade
|
| Net Debt / Equity Ratio | 0.41 | 0.73 | 0.73 | 0.63 | 0.43 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.24 | 3.23 | -5.24 | -2.92 | -2.85 | 2.43 | Upgrade
|
| Net Debt / FCF Ratio | 14.33 | 6.85 | -2.64 | -1.97 | -2.75 | 16.09 | Upgrade
|
| Asset Turnover | 0.99 | 1.02 | 0.95 | 0.94 | 0.85 | 0.92 | Upgrade
|
| Inventory Turnover | 3.76 | 4.42 | 4.23 | 4.44 | 3.97 | 4.07 | Upgrade
|
| Quick Ratio | 0.48 | 0.52 | 0.41 | 0.44 | 0.59 | 0.74 | Upgrade
|
| Current Ratio | 0.94 | 0.92 | 0.69 | 0.91 | 0.84 | 1.26 | Upgrade
|
| Return on Equity (ROE) | 10.56% | -7.17% | -42.25% | -76.68% | -47.91% | -5.13% | Upgrade
|
| Return on Assets (ROA) | 2.01% | 1.19% | -5.27% | -6.75% | -5.17% | 0.57% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.72% | 3.82% | -16.60% | -25.79% | -18.97% | 1.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.60% | 3.60% | -19.80% | -21.30% | -15.50% | 1.30% | Upgrade
|
| Earnings Yield | 2.87% | -1.39% | -15.71% | -18.52% | -12.48% | -2.90% | Upgrade
|
| FCF Yield | 0.69% | 5.36% | -9.91% | -8.55% | -3.25% | 1.11% | Upgrade
|
| Dividend Yield | 0.60% | - | - | - | - | - | Upgrade
|
| Payout Ratio | 0.22% | - | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -2.17% | -3.34% | -2.61% | -10.76% | 0.00% | 0.02% | Upgrade
|
| Total Shareholder Return | -1.56% | -3.34% | -2.61% | -10.76% | 0.00% | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.